Concert Pharmaceuticals, Inc.

99 Hayden Avenue, Suite 500,
Lexington, Massachusetts 02421
United States,
781.860.0045
www.concertpharma.com

Concert was founded to utilize novel chemistry approaches to developing drugs. Concert utilizes advanced chemical methodology to rapidly create potent, bioavailable drug candidates. Concert’s Board of Directors is chaired by Rich Aldrich, Chairman of RA Capital Management; and includes Wilf Jaeger, Partner and founder of Three Arch Partners; Stephen J. Hoffman, general partner of TVM Capital; John Freund, managing director and founder of Skyline Ventures; Christoph Westphal, CEO and vice-chairman of Sirtris Pharmaceuticals; and Roger Tung, President and CEO of Concert.

M&A Summary

Buy vs Sell

Year ≤ '12 '13 '14 '15 '16 '17 T
Buy (0.0/yr) # - - - - - - 0
Sell (0.2/yr) # - - - - - 1 1
vol $160M $160M
  1

Top M&A Advisors

Financial Deals
Join to Access.
Legal Deals
Join to Access.

Deal Values

Buy # TOTAL
> $1B Sign-up to View
$100M to $1B Sign-up to View
< $100M Sign-up to View
TOTAL Sign-up to View
Sell # Total
> $1B Sign-up to View
$100M to $1B Sign-up to View
< $100M Sign-up to View
Total Sign-up to View
Largest Concert Pharmaceuticals, Inc. - CTP-656
$160M (2017-03-06)

According to our data here at Mergr, Concert Pharmaceuticals has acquired 0 company. It has also divested 1 asset.

It’s largest disclosed sale occurred in 2017, when it sold Concert Pharmaceuticals - CTP-656 to Vertex Pharmaceuticals for $160M.

When analyzing the life science sector as a whole, according to Mergr, in the last 3 years, there are 410 life science companies that have made at least 1 acquisition, 23 have acquired at least 5 companies, and 3 have acquired more than 10 companies. The most prolific strategic life science acquirer over the past 3 years is Eurofins Scientific SA, with 25 acquisitions. The most prolific private equity acquirer in the life science sector over the past 3 years is Ampersand Capital Partners with 4 platform acquisitions.

Join Mergr and gain access to Concert Pharmaceuticals’ M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.


What's Mergr?

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 3.3K Private Equity Firms
  • 113K M&A Transactions
  • 123K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 2.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 37K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.